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Objective: To describe the values of non-HDL cholesterol (NHDL-c) and the 
frequency of a family history of early cardiovascular disease (family HCVD) in 
healthy prepubescent children. Analyze the association between NHDL-c and 
family HCVD, and possible associations with other risk factors for cardiovascu-
lar disease (CVD). 
Method: Cross-sectional study including 269 prepubescent (aged 6-10 years) 
schoolchildren with a normal body mass index (+1SD<BMI>-2SD). Data col-
lected: Family HCVD; weight and height, waist circumference and systemic blood 
pressure; lipid profile (total cholesterol TC, HDL-c, triglycerides and LDL-c), 
NHDL-c calculation (CT-HDL-c, cut-off = 145 mg/dL) and insulin resistance 
(HOMA-IR). 
Results: High levels were found for NHDL-c in 10 (3.7%) of these schoolchil-
dren, and family early HCVD was found in 46 (17.1%) of them. There was a weak 
association between family HCVD and NHDL-c (Cramer’s-V-test = 0.120; p=0.050). 
Among the children with NHDL-c≥145 mg/dL, 4 (40%) have family HCVD. The 
presence of family HCVD was not associated with the variables being studied. 
The variables independently associated with NHDL-c ≥ 145 mg/dL were: HOMA-
IR (OR=1.7; 95CI 1.1-2.6) and diastolic blood pressure (OR=1.1; 95CI 1.02-1.2). 
Conclusion: NHDL-c values were associated with blood pressure and insulin 
resistance. Family HCVD was not associated with other classic risk factors for 
CVD, even though the frequency found was five times higher than that of high 
NHDL-c.
Keywords: dyslipidemias, cardiovascular diseases, child, primary prevention.
introduction
Cardiovascular diseases (CVD) are the leading cause of 
mortality in adults worldwide.1 In Brazil, they also stand 
out as the leading cause of death, with rates of 28.8% and 
36.9% for men and women, respectively.2
Atherosclerosis begins in childhood and progresses 
during adolescence and adulthood, and early identifica-
tion is a crucial step toward reducing the morbidity and 
mortality related to it. The study by Bogalusa confirmed 
this finding when evaluating the autopsies of 204 healthy 
children and young adults between 2 and 39 years of age, 
who died due to trauma, and described the presence of 
fatty plaques in the aorta and coronary arteries in 50% of 
individuals aged between 2 and 15 years.3 The authors 
also noted that the greater the number of classic risk fac-
tors (obesity, dyslipidemia, diabetes mellitus, hypertension, 
and smoking) for CVD present, the greater the frequen-
cy and extent of the lesions.3,4
According to the American Academy of Pediatrics,5 
the investigation of CVD risk factors in children and ad-
olescents is recommended regardless of the nutritional 
condition, and its central point is the presence of a fami-
ly history of early CVD (HCVD).5 According to this rec-
ommendation, children from 2 to 8 years of age with HCVD 
and all children aged from 9 to 11 years should have their 
lipid profile evaluated. The proposal for this evaluation is 
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to use the dosage of non-HDL cholesterol (NHDL-c) as 
initial screening, establishing the complete lipid profile if 
NHDL-c values are equal to or greater than 145 mg/dL.5
The search for risk factors for CVD in the clinical his-
tory of children is one of the goals that should be incor-
porated into pediatric care. However, the need for com-
plement the investigation through subsidiary exams in 
healthy children is still not consolidated in literature.
The aim of this study was to describe the values of 
NHDL-c and frequency of HCVD in healthy and prepubes-
cent children, in addition to checking possible associations 
between NHDL-c and HCVD with other CVD risk factors.
Method
By means of an anthropometric census conducted by the 
Division of General and Community Pediatrics, Pediat-
rics Department of the Federal University of São Paulo, 
in São Paulo, Brazil, 920 schools children were invited to 
participate in this cross-sectional study. We evaluated 
766/920 (83.3%) children aged 6 to 10 years, whose par-
ents had signed an informed consent form. Among these 
children, 540/766 (70.5%) presented a normal body mass 
index (BMI). Next, the children who already showed sec-
ondary sex characteristics and those who had not collect-
ed blood samples were excluded, totaling 269/540 (49.8%) 
prepubescent schoolchildren (117 girls and 152 boys), be-
tween 6 and 10 years old with a normal BMI (1SD < BMI 
> -2 SD; World Health Organization, 2007).6
This study was approved by the Ethics Committee of 
the Institution (São Paulo, Brazil no. 1568/09) and, in or-
der to participate, the parents/guardians of the children 
signed an informed consent form.
A pre-coded questionnaire was applied to the parents/
guardians of the children to obtain information on birth 
weight and prematurity, to search for pre-existing diseases 
and investigate family history for CVD (HCVD).5 A family 
history was considered to be present when the parents re-
ported high blood pressure, diabetes, obesity or hypercho-
lesterolemia. As the parents of these schoolchildren were 
perhaps too young to show evident coronary disease, we also 
considered a positive history the occurrence of myocardial 
infarction or sudden death in the grandparents before 55 
years of age. Staging of puberty was performed by a pedia-
trician as per the recommendations of Tanner & Marshall.7
Weight data was obtained on platform-type mechan-
ical scales (SD-150, Country Technologies, Wisc, USA), 
graduated every 0.1 kg, with the child using the least pos-
sible amount of clothing, without shoes, while height mea-
surement was done on a vertical stadiometer graduated 
in millimeters (1 mm).8 This data was used for classifica-
tion of nutritional status using the indicators and cut-off 
points proposed by the World Health Organization, 2007. 
They were considered healthy if 1SD < BMI > -2 SD.6
Waist circumference (WC) was measured with an in-
extensible tape measure at the midpoint between the up-
per iliac crest and the last fixed rib. Values higher than 
the 90 percentile according to sex and age were consid-
ered unsuitable.9 WC was also used to calculate the waist/
height ratio (cut-off point < 0.5).10
Blood pressure (SBP – systolic and DBP – diastolic) 
was measured using a sphygmomanometer by a single 
evaluator, and recorded from the average of three mea-
surements, with five minutes intervals, in a single session. 
High blood pressure included values above the 90 per-
centile for gender, age and height.11
Blood collection: After 12 hours of fasting, 5 mL of 
blood were collected via peripheral venipuncture for de-
termination of the lipid profile, blood glucose and insu-
lin. The samples were centrifuged after one hour (1500 
rpm for five minutes), aliquoted and used for determina-
tion of plasma concentrations of total cholesterol (TC), 
HDL-c, triglycerides (TG) (colorimetric method) and LDL-
c (Friedewald equation). The cut-off points used were those 
proposed by the American Academy of Pediatrics, 2008.12 
Based on the lipid profile we calculated the non-HDL cho-
lesterol (TC – HDL-c; cut-off point <145 mg/dL).13 Blood 
concentrations of glucose (colorimetric method) and in-
sulin (chemiluminescence) were used for the evaluation 
of insulin resistance under the homeostatic model assess-
ment calculation (HOMA-IR; glucose (mg/dL)/18 x insu-
lin (mIU/mL)]/22.5). The cut-off point for blood glucose 
was <100 mg/dL and HOMA-IR <2.0.14
The data collected was typed and consolidated in an 
Excel® spreadsheet. SPSS 20.0 (IBM) statistics software 
was used for analysis. The continuous variables were test-
ed as to their normality through using Shapiro-Wilk test, 
and Student’s t-test for parametric variables and the 
Mann-Whitney U test for nonparametric variables. Cat-
egorical variables were compared using chi-squared test 
or Fisher’s exact test. Cramer’s V test was used to evalu-
ate the association between HCVD and NHDL-c. For the 
multivariate analysis we used the Forward LR logistic re-
gression method and included those with p<0.1 in the bi-
variate analysis. A significance level of 5% was adopted.
results
Among the children evaluated, 58.7% were boys and the me-
dian age was 8.3 years (6.0;10.9). The frequency of changes 
in the variables studied can be observed in Table 1. A high 
percentage of unsuitability was found in relation to the lip-
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id profile, especially for triglycerides: 92 (34.2%) and HDL-
c: 91 (33.8%). No children included in the study had an in-
creased waist circumference or waist/height ratio above 0.5.
TABLE 1 Frequency of clinical and laboratorial changes 
as variables studied in healthy and prepubescent 
schoolchildren.
Variable Total (n=269)
Birth weight <2500 g 35 (13%)
Family HCVD Present 46 (17.1%)
Systolic BP ≥p90 3 (1.1%)
Diastolic BP ≥p90 12 (4.5%)
HOMA-IR >2.0 50 (23.9%)
Blood glucose ≥100 mg/dL 4 (1.4%)
Borderline High
Triglycerides 75-99 and ≥100 65 (24.2%) 36 (13.3%)
TC 170-199 and ≥200 60 (22.3%) 5 (1.8%)
HDL-c <40 and ≥45 71 (26.4%) 24 (8.9%)
LDL-c 100-129 and ≥130 35 (13.0%) 7 (2.6%)
NHDL-c 120-145 and ≥145 52 (19.3%) 10 (3.7%)
HCVD: history for cardiovascular disease; BP: blood pressure; HOMA-IR: homeostatic model 
assessment – insulin resistance; TC: total cholesterol; HDL-c: high-density lipoprotein choles-
terol; LDL-c: low-density lipoprotein cholesterol; NHDL-c: non-HDL cholesterol.
The median of the values for NHDL-c was 102.0 mg/dL 
(47.0;187.0), with no statistically significant difference be-
tween genders (data not shown).
In the population studied, high NHDL-c was found 
in 10 (3.7%) children, and HCDV was found in 46 (17.1%). 
A weak association was found between family HCVD and 
NHDL-c (Cramer’s V test=0.120; p=0.050). Among chil-
dren with NHDL-c ≥145 mg/dL, 4 (40%) had a family his-
tory of CDV.
The presence of HCDV was not associated in a statis-
tically significant manner with the variables studied (Ta-
ble 2). Although there was no difference, the group of chil-
dren with HCVD had higher median values of NHDL-c 
compared to the schoolchildren without HCVD (Table 2).
The variables that were independently associated with 
NHDL-c were HOMA-IR and PAD (Table 3). The increase 
of one unit in HOMA-IR and PAD was associated with 
OR=1.7 (95% CI 1.1-2.6) and OR=1.1 (1.02-1.02) for un-
suitability of NHDL-c, respectively.
discussion
In this study of healthy and prepubescent schoolchildren, 
risk factors for CVD were found, both clinically and con-
nected to the metabolic and lipid profile of this popula-
tion. Among the predictors analyzed (family HCVD and 
NHDL-c), NHDL-c values above 145 mg/dL were associ-
ated with a greater number of factors related to the de-
velopment of CVD (DBP and HOMA-IR) than family his-
tory alone. Furthermore, a weak association was noted 
between HCVD and increased NHDL-c.
The investigation of HCVD in the pediatric age range 
has been debated intensively in recent years in view of the 
increase in morbidity and mortality caused by CVD in 
the general population.5 Obesity and associated morbid-
ities are well-known and widely investigated risk factors.3,4 
Nevertheless, there are few studies addressing HCVD in 
healthy children. Currently, there is no consensus about 
who, when and how to investigate HCVD in this group.
In a recent publication on guidelines for the reduction 
of cardiovascular risk in children, the authors suggest that 
family HCVD is the central item to defining the need to 
TABLE 2 Comparison of the variables studied in children for the presence of family history of cardiovascular disease.
Variable HCVD (+)
(n=46)
HCVD (-)
(n=223)
p-value
Age years 8.6 (6.1;10.9) 8.3 (6.0;10.9) 0.225*
Birth weight grams 3020 (1250;4400) 3180 (875;4830) 0.243*
BMI z-score 0.06 (-1.7;0.9) -0.23 (-1.9;0.9) 0.248*
Waist/height cm 0.42 (0.4;0.5) 0.42 (0.2;0.5) 0.569*
Systolic BP mmHg 90.0 (80.0;110.0) 90.0 (70.0;120.0) 0.213*
Diastolic BP mmHg 60.0 (40.0;80.0) 60.0 (40.0;80.0) 0.173*
HOMA-IR 1.2 (0.3;6.7) 1.0 (0.1;7.0) 0.356*
Blood glucose mg/dL 81.0 (69.0;103.0) 80.0 (46.0;107.0) 0.064*
Insulin uU/mL 6.3 (1.4;31.0) 5.6 (1.0;31.8) 0.446*
NHDL-c mg/dL 109.5 (61.0;187.0) 101.0 (47.0;161.0) 0.060*
Gender male 24 128 0.519†
*Level of significance in Mann-Whitney test.
†Level of significance in Chi-squared test. 
BMI: body mass index; BP: blood pressure; HOMA-IR: homeostatic model assessment – insulin resistance; NHDL-c: non-HDL cholesterol.
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widen the investigation of CVD risk in healthy children or 
not.5 In practice, despite being simple to collect, the inter-
pretation of this data in the scope of clinical history has 
certain obstacles. The report about the family is sometimes 
unnecessary. The most robust evidence relates to first-de-
gree relatives (parents) who are often too young to have 
more serious cardiovascular outcomes.3,5 Much of the young 
adult population has not yet adopted routine lipid profil-
ing, which is one of the factors evaluated in family HDCV. 
In the general population, there is a high prevalence of dys-
lipidemia, hypertension and diabetes related to obesity and 
lifestyle, which makes the differentiation of environmen-
tal and genetic factors difficult.15
In our study, we found that family HCVD was not as-
sociated with other classical risk factors for CVD, although 
the frequency found was almost five times higher for high 
NHDL-c and the median values of NHDL-c tend to be 
higher in the group with family HCVD. These findings 
are consistent with those observed in a large population 
study (Coronary Artery Risk Detection in Appalachian 
Communities – CARDIAC project) where the authors 
found that family history failed to identify dyslipidemia 
(LDL-c>130 mg/dL) in healthy subjects.16
According to the American Academy of Pediatrics,5 
universal screening for dyslipidemia is recommended in 
children aged 9 to 11 years based on determination of the 
lipid profile without the need of fasting and the calcula-
tion of the NHDL-c. If these values are above 145 mg/dL, 
another lipid profile should be requested within two weeks 
(total cholesterol and fractions) under 12-hour fasting 
and with individual analysis of the fractions. This uni-
versal investigation can also be conducted in children 
aged 2 to 9 years if there is family HCVD and avoided in 
children younger than 2 years for there are no established 
cut-off points, as well as in adolescents, considering that 
there is a physiological decrease in concentrations of li-
poproteins, especially LDL-c, during puberty.5
NHDL-c has been presented in recent publications 
as the best predictor of CVD in the long-term compared 
with other components of the lipid profile, such as total 
cholesterol, LDL-c and the LDL/HDL ratio. A cohort 
study (Bogalusa Heart Study) noted that the NHDL-c val-
ues in childhood are more strongly associated with the 
thickness of the intima-media complex of the carotid in 
young adults.17
The calculation of NHDL-c is simple and fasting is 
not required for its evaluation. NHDL-c measures the 
atherogenic particles that contain the apolipoprotein 
(LDL-c, small and dense particles, VLDL-c, chylomicron 
remnants, IDL-c).18 In our study, NHDL-c values ≥145 
mg/dL were independently associated with diastolic blood 
pressure and insulin resistance as measured by HOMA-
IR. These findings are similar to those seen in the publi-
cation of the group from the Bogalusa Heart Study.12 Also, 
NHDL-c can be considered a predictor of type 2 diabetes 
mellitus.19
A recent American population study found the aver-
age and percentage of unsuitability of NHDL-c at 110 
mg/dL and 11.8%, respectively, in the age range between 
9 and 11 years.13 These results are higher than those de-
scribed in our study, which were 102 mg/dL and 3.7%.
Despite this set of findings, universal screening based 
on NHDL-c is not yet a consensus. Critics suggest that it 
is based on weak evidence, that there are no cost-benefit 
TABLE 3 Comparison of the variables studied in children regarding concentrations of non-HDL cholesterol (NHDL-c).
Variable NHDL-c ≥145 mg/dL 
(n=10)
NHDL-c <145 mg/dL 
(n=259)
p-value
Age years 9.3 (6.0;10.0) 8.3 (5.0;10.0) 0.185*
Birth weight grams 2820 (2080;3878) 3180 (875;4830) 0.300*
BMI z-score 0.20 (-1.5;0.8) -0.15 (-1.9;0.9) 0.647*
Waist/height cm 0.43 (0.4;0.5) 0.42 (0.2;0.5) 0.213*
Systolic BP mmHg 92.5 (80.0;100.0) 90.0 (70.0;120.0) 0.063*
Diastolic BP mmHg 65.0 (50.0;80.0) 60.0 (40.0;80.0) 0.008*
HOMA-IR 2.2 (1.3;7.0) 1.05 (0.1;6.6) <0.001*
Blood glucose mg/dL 85.5 (70.0;95.0) 80.0 (46.0;107.0) 0.103*
Insulin IU/mL 9.9 (6.6;31.8) 5.5 (1.0;31.0) <0.001*
Gender male 6 (60%) 146 (56.3%) 0.544†
Cardiovascular risk present 4 (40%) 42 (16.2%) 0.073†
* Level of significance in Mann-Whitney test.
† Level of significance in Chi-squared test. 
BMI: body mass index; BP: blood pressure; HOMA-IR: homeostatic model assessment – insulin resistance.
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studies in the short and long term, that this investigation 
may lead to greater anxiety in the family, increased adop-
tion of restrictive diets and the use of lipid-lowering med-
ication at pediatric age.20
In our study, only 10 (3.7%) of the children would re-
quire another blood collection for determination of the 
lipid profile, according to the recommendation for uni-
versal screening. On the other hand, if we were to use the 
family HCVD alone, this figure would be five times high-
er. The study model does not allow us to define what 
would be better in the study of CVD risk in this popula-
tion. However, it is clear that this topic needs to be fur-
ther explored and discussed, in order to define the best 
practice for the pediatric routine in view of the high prev-
alence of CVD in our population.
A greater number of schoolchildren participating in 
the study could statistically confirm the trend observed 
between the higher systolic BP in the group with high 
NHDL-c and the higher NHDL-c levels in the group with 
family HCVD. Another limitation refers to not having 
used more accurate methods to assess the risk of CVD, 
such as intima-media thickness.
conclusion
This study demonstrated NHDL-c values associated with 
CVD risk factors such as blood pressure and insulin resis-
tance. Family HCVD was not associated with classical risk 
factors for CVD, although the frequency of positive HCVD 
found was almost five times higher than that of high 
NHDL-c. The identification of early HCVD in children 
should be part of the pediatric routine, regardless of nu-
tritional status, and a healthy lifestyle should be proposed 
and encouraged for both the child and the family.
resuMo
Importância clínica da história familiar de doença car-
diovascular e da dosagem do colesterol não HDL em crian-
ças eutróficas
Objetivos: descrever os valores do colesterol não HDL 
(NHDL-c) e a frequência de história cardiovascular fami-
liar precoce (HDCV familiar) em crianças eutróficas e pré-
-púberes. Analisar a associação entre o NHDL-c e o HDCV 
familiar e possíveis associações com outros fatores de ris-
co para doenças cardiovasculares (DCV). 
Método: estudo transversal com 269 escolares (6-10 anos) 
pré-púberes e com índice de massa corporal normal 
(+1DP<IMC>-2DP). Dados coletados: HDCV familiar; 
peso e estatura, circunferência abdominal e pressão arte-
rial sistêmica; perfil lipídico (colesterol total – CT, HDL-
-c, triglicérides e LDL-c), cálculo do NHDL-c (CT-HDL-c, 
ponto de corte 145 mg/dL) e resistência à insulina (HO-
MA-IR). 
Resultados: observaram-se valores elevados de NHDL-c 
em 10 (3,7%) e presença de HDCV familiar precoce em 46 
(17,1%) crianças. Houve fraca associação entre HDCV fa-
miliar e NHDL-c (Cramer’s-V-test = 0,120; p=0,050). En-
tre as crianças com NHDL-c ≥145 mg/dL, quatro (40%) 
tinham HDCV familiar. A presença de HDCV familiar 
não se associou com as variáveis estudadas. As variáveis 
que se associaram de forma independente com o NHDL-
-c ≥145 mg/dL foram HOMA-IR (OR=1,7; IC95% 1,1-2,6) 
e pressão arterial diastólica (OR=1,1; IC95% 1,02-1,2). 
Conclusão: os valores de NHDL-c se associaram com 
pressão arterial e resistência insulínica. HDCV familiar 
não se associou com outros fatores de risco clássicos para 
DCV, embora a frequência encontrada tenha sido quase 
cinco vezes superior à de NHDL-c elevado.
Palavras-chave: dislipidemias, doenças cardiovasculares, 
criança, prevenção primária.
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